Overview
Sarah Lord is a primary care provider, practicing in Internal Medicine in Chesterfield, Missouri. Dr. Lord is rated as an Experienced provider by MediFind in the treatment of Idiopathic Edema. Her top areas of expertise are Hypertension, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, and Celiac Disease. Dr. Lord is currently accepting new patients.
Her clinical research consists of co-authoring 2 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
121 Saint Lukes Ctr Dr, Suite 504, Chesterfield, MO 63017
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Osf Multi-Specialty Group
Colin Butterfield is a primary care provider, practicing in Internal Medicine in Alton, Illinois. Dr. Butterfield has been practicing medicine for over 44 years and is rated as a Distinguished provider by MediFind in the treatment of Idiopathic Edema. His top areas of expertise are Doxorubicin-Induced Cardiomyopathy, Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, and Hypertension. Dr. Butterfield is currently accepting new patients.
Abbott And Associates, Inc.
David Abbott is a primary care provider, practicing in Geriatrics and Internal Medicine in Saint Louis, Missouri. Dr. Abbott is rated as an Advanced provider by MediFind in the treatment of Idiopathic Edema. His top areas of expertise are Alzheimer's Disease, Hypertensive Heart Disease, Pediatric Myocarditis, and Enlarged Liver. Dr. Abbott is currently accepting new patients.
Drs. Mera, Boesch And Kumar, LLC
Jeffrey Boesch is a primary care provider, practicing in Internal Medicine in Chesterfield, Missouri. Dr. Boesch is rated as a Distinguished provider by MediFind in the treatment of Idiopathic Edema. His top areas of expertise are Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, Hypertension, and Acute Mountain Sickness. Dr. Boesch is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Celiac DiseaseDr. Lord isExperienced. Learn about Celiac Disease.
- Chromophobe Renal Cell CarcinomaDr. Lord isExperienced. Learn about Chromophobe Renal Cell Carcinoma.
- Chronic CoughDr. Lord isExperienced. Learn about Chronic Cough.
- Clear Cell SarcomaDr. Lord isExperienced. Learn about Clear Cell Sarcoma.
- Familial HypertensionDr. Lord isExperienced. Learn about Familial Hypertension.
- Familial Wilms Tumor 2Dr. Lord isExperienced. Learn about Familial Wilms Tumor 2.